OrthoPediatrics Corp. (KIDS) Fair Value 2026

KIDS · Medical Devices ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

7.1 /10

32 fundamental signals · 1 models active

Value Trap Risk

SAFE (13/100)

Quick Summary — As of 2026-08-28, OrthoPediatrics Corp. (KIDS) trades at $23.65. QOC: 7.1/10. Value Trap Risk: 13/100 (SAFE). 1/13 models active.

Key Facts

Ticker
KIDS
Price
$23.65
Quality Score
7.1/10
Value Trap Risk
13/100
Models Active
1/13
Last Updated
Strength: 1 independent models provide multi-angle coverage
Risk: Majority of models suggest overvaluation

What Fair Value Does Each Model Give KIDS?

1 Intrinsic Value Models vs. Current Price ($23.65)

Core Models (Unlocked)
Model Fair Value Upside
Asset-Based · High Conviction
 $4.26 -82.0%

All Models Active

All 1 models are displayed above.

What Is OrthoPediatrics Corp. (KIDS) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, OrthoPediatrics Corp.'s intrinsic value is estimated at $4.26, suggesting the stock is overvalued at its current price of $23.65. With 1 out of 1 models flagging downside (-82.0% vs price), the market may be pricing in unsustainable growth.

What Do the Models Say About KIDS?

1 of 13 models are currently active for KIDS. All 1 active models suggest the stock trades above fair value. See which stocks rank higher →

How Does KIDS Rank in Medical Devices?

Among 159 Medical Devices stocks, KIDS ranks #45 by Quality of Company score. CirclFi's QOC score of 7.1/10 evaluates 32 fundamental signals. A score of 7.1 indicates above-average quality.

See all Most Undervalued Medical Devices Stocks →

Within the Medical Devices space, OrthoPediatrics Corp. competes in an environment where biosimilar competition timeline often separates market leaders from laggards. Understanding these industry-specific dynamics is essential context for interpreting our model outputs.

Is KIDS a Value Trap?

CirclFi's Value Trap algorithm assigns KIDS a score of 13/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

1 of 13 models are active for OrthoPediatrics Corp.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, OrthoPediatrics Corp. is rated at 7.1/10. This solid-tier score maintains reasonable quality metrics with some areas for improvement.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every KIDS valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across KIDS's 1 active models, average confidence is 58%. Moderate confidence indicates reasonable fit.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy OrthoPediatrics Corp. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Devices Stocks Should You Also Analyze?

11 related Medical Devices stocks with 13-model coverage

PHGKoninklijke Philips N.V.QOC 7.1NVCRNovoCure LimitedQOC 7.1IARTIntegra LifeSciences Holdings CorporationQOC 7.1LNSRLENSAR, Inc.QOC 7.1LUNGPulmonx CorporationQOC 7.2IRTCiRhythm Holdings, Inc.QOC 7.1OMOutset Medical, Inc.QOC 6.1VVOSVivos Therapeutics, Inc.QOC 5.0UFPTUFP Technologies, Inc.QOC 9.2IRMDIRADIMED CORPORATIONQOC 9.8PODDInsulet CorporationQOC 9.6

Read investment analysis: PHG · NVCR · IART · LNSR · LUNG · IRTC · OM · VVOS · UFPT · IRMD · PODD

Which Other Stocks Have a Similar Quality Score to KIDS?

7 companies across all industries closest to KIDS’s Quality of Company score of 7.1/10.

KKRKKR & Co. Inc.QOC 7.1IRWDIronwood Pharmaceuticals, Inc.QOC 7.1FINWFinWise BancorpQOC 7.1BBUCBrookfield Business CorporationQOC 7.1STSensata Technologies Holding plcQOC 7.1CNRCore Natural Resources, Inc.QOC 7.1NVDANVIDIA CorporationQOC 10.0

Read investment analysis: KKR · IRWD · FINW · BBUC · ST · CNR · NVDA

Where Does KIDS Sit in CirclFi's Medical Devices Rankings?

KIDS is ranked against every other Medical Devices stock CirclFi covers in each of these screens.

See all Medical Devices stocks ranked →

What Else Do Investors Ask About OrthoPediatrics Corp.’s Valuation?

What is OrthoPediatrics Corp.'s intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for OrthoPediatrics Corp. (KIDS). The Quality of Company score is 7.1/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is KIDS overvalued or undervalued right now?

At $23.65, 0 of 1 active models suggest KIDS may be undervalued, while 1 indicate potential overvaluation. The assessment depends on which methodology best fits OrthoPediatrics Corp.'s business model in Medical Devices.

What does a Quality of Company score of 7.1 mean for KIDS?

OrthoPediatrics Corp.'s QOC of 7.1/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on KIDS?

CirclFi analyzes KIDS with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 1 of 13 are active for this stock. Read the full methodology →

Is KIDS a value trap in 2026?

OrthoPediatrics Corp.'s Value Trap score is 13/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns OrthoPediatrics Corp. (KIDS) a Quality of Company score of 7.1/10 across 32 fundamental signals as of 2026-08-28.” Source: circlfi.com/stock/KIDS/ · Methodology
Primary sources for this KIDS valuation
  • Financial statements: OrthoPediatrics Corp. 10-K and 10-Q filings on SEC EDGAR (CIK 0001425450) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for KIDS as of ; valuations recomputed .